Table 1.
Basic demographic and clinical characteristics of the patients included in the study
| Heart failure patients (n = 46) | Value |
|---|---|
| Age (year), mean ± SD (min‐max) | 70.6 ± 7.9 (56‐85) |
| Gender, n (%) | |
| Male | 35 (76,1) |
| Female | 11 (23,9) |
| Height (m), mean ± SD (min‐max) | 1.7 ± 0.1 (1.5‐1.8) |
| Weight (kg), mean ± SD (min‐max) | 73.4 ± 13.4 (51‐105) |
| BMI (kg/m2), mean ± SD (min‐max) | 26.6 ± 4.4 (19.6‐37.1) |
| Etiology of heart failure, n (%) | |
| Non‐ischemic | 25 (54,3) |
| Ischemic | 21 (45,7) |
| Duration of heart failure (year), mean ± SD (min‐max) | 8.0 ± 4.0 (3‐20) |
| Diabetes mellitus, n (%) | 12 (26,1) |
| Hypertension, n (%) | 26 (56,5) |
| Hyperlipidemia, n (%) | 9 (19,6) |
| Smoking, n (%) | 15 (32,6) |
| Optimal medical therapy, n (%) | 46 (100) |
| NYHA Class, n (%) | |
| II | 25 (54,3) |
| III | 15 (32,6) |
| III/IV | 6 (13,0) |
| ECG (branch block), n (%) | |
| Left bundle branch block (LBBB) | 38 (82,6) |
| Other branch blocks | 8 (17,4) |
| GFR (mL /min/1,73 m2), mean ± SD (min‐max) | 62.5 ± 20.6 (21.8‐98.1) |
| Basal echocardiography parameters, mean ± SD (min‐max) | |
| LVEDD (mm) | 61.8 ± 9.8 (42‐91) |
| LVESD (mm) | 52.7 ± 10.3 (32‐81) |
| LA (anterior‐posterior diameter) (mm) | 45.0 ± 5.0 (30‐54) |
| Ejection fraction (%) | 28.1 ± 5.0 (16‐36) |
| LVOT VTI | 13.3 ± 3.7 (6.7‐21.8) |
Abbreviations: BMI, Body Mass Index; GFR, Glomerular filtration index; LA, Left atrium; LVEDD, Left ventricular end diastolic diameter; LVESD, Left ventricular end systolic diameter; LVOT VTI, Left ventricular outflow tract velocity time index; n, Number of patients; NYHA, New York Heart Association; SD, Standard deviation; %, Percent.